Catherine Sekerke

861 citations

19 papers · 645 indexed · h-index 16

Molecular Biology
Organic Chemistry top 10%
Surgery
Computational Theory and Mathematics top 5%
Pharmacology

Co-authors: Peter O. Kwiterovich Roger S. Newton Bruce D. Roth Drago R. Sliskovic Erika Ferguson Sharmistha Chatterjee Bruce J. Auerbach C. John Blankley
Topics: Lipoproteins and Cardiovascular Health (11 papers)Computational Drug Discovery Methods (6 papers)Plant biochemistry and biosynthesis (6 papers)
Cited by: Organic Chemistry Computational Theory and Mathematics Biotechnology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Biochemical and Biophysical Research Communications
Partner nations: United States China

In The Last Decade

Catherine Sekerke

19 papers receiving 610 citations

Peers

Countries citing papers authored by Catherine Sekerke

Since Specialization

Citations

This map shows the geographic impact of Catherine Sekerke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Sekerke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Sekerke more than expected).

Fields of papers citing papers by Catherine Sekerke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Sekerke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Sekerke. The network helps show where Catherine Sekerke may publish in the future.

Co-authorship network of co-authors of Catherine Sekerke

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Sekerke. A scholar is included among the top collaborators of Catherine Sekerke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Sekerke. Catherine Sekerke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Hepatoselectivity of statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·William K.C. Park,Robert M. Kennedy,Scott D. Larsen,Steve Miller,Bruce D. Roth,Yuntao Song,Bruce A. Steinbaugh,(unknown),Bradley D. Tait,Mark C. Kowala,Bharat K. Trivedi,Bruce J. Auerbach,(unknown),(unknown),Jeffrey C. Hanselman,Zhiwu Lin,Gina H. Lu,Andrew Robertson,Catherine Sekerke	45
2	Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey A. Pfefferkorn,Chulho Choi,Yuntao Song,Bharat K. Trivedi,Scott D. Larsen,(unknown),(unknown),Jeffrey C. Hanselman,Zhiwu Lin,Gina H. Lu,Andrew Robertson,Catherine Sekerke,Bruce J. Auerbach,A.G. Pavlovsky,Melissa S. Harris,Graeme Bainbridge,Nicole Caspers	30
3	Pyrazole inhibitors of HMG-CoA reductase: An attempt to dramatically reduce synthetic complexity through minimal analog re-design 2007 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Larsen,(unknown),Kevin J. Filipski,Jeffrey T. Kohrt,Jeffrey A. Pfefferkorn,Roderick J. Sorenson,Bradley D. Tait,(unknown),(unknown),Jeffrey C. Hanselman,Gina H. Lu,Andrew Robertson,Catherine Sekerke,Mark C. Kowala,Bruce J. Auerbach	11
4	Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase 2007 ·Bioorganic & Medicinal Chemistry ·(unknown),Bruce J. Auerbach,Chulho Choi,(unknown),Jeffrey C. Hanselman,Scott D. Larsen,Gina H. Lu,Karl Olsen,Jeffrey A. Pfefferkorn,Andrew Robertson,Catherine Sekerke,Bharat K. Trivedi,Paul C. Unangst	25
5	Substituted Pyrazoles as Hepatoselective HMG-CoA Reductase Inhibitors: Discovery of (3R,5R)-7-[2-(4-Fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic Acid (PF-3052334) as a Candidate for the Treatment of Hypercholesterolemia 2007 ·Journal of Medicinal Chemistry ·Jeffrey A. Pfefferkorn,Chulho Choi,Scott D. Larsen,Bruce J. Auerbach,R. H. Hutchings,(unknown),(unknown),(unknown),Jeffrey C. Hanselman,Zhiwu Lin,Gina H. Lu,Andrew Robertson,Catherine Sekerke,Melissa S. Harris,A.G. Pavlovsky,Graeme Bainbridge,Nicole Caspers,Mark C. Kowala,Bradley D. Tait	44
6	CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys 1998 ·Atherosclerosis ·(unknown),Mark A. Spahr,Catherine Sekerke,Richard L. Stanfield,Richard F. Bousley,Helen T. Lee,(unknown)	24
7	Development, Validation, and Interlaboratory Comparison of an HMG-CoA Reductase Inhibition Assay for Quantitation of Atorvastatin in Plasma Matrices 1998 ·Therapeutic Drug Monitoring ·(unknown),(unknown),Gary A. Walter,Ann E. Black,Catherine Sekerke,Tsun Chang,Lloyd R. Whitfield	18
8	Retinoids Inhibit Primary Cynomolgus Monkey Hepatocyte Lipoprotein(a) Levels 1997 ·Biochemical and Biophysical Research Communications ·(unknown),Mark A. Spahr,Catherine Sekerke	4
9	Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors 1997 ·Journal of Lipid Research ·C L Bisgaier,Arnold D. Essenburg,Bruce J. Auerbach,M E Pape,Catherine Sekerke,Andrew Gee,(unknown),Roger S. Newton	66
10	Expression of apolipoprotein[a] and plasminogen mRNAs in cynomolgus monkey liver and extrahepatic tissues 1996 ·Journal of Lipid Research ·(unknown),Mark A. Spahr,(unknown),Catherine Sekerke	24
11	Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase. 1993 ·Journal of Pharmacology and Experimental Therapeutics ·Brian R. Krause,Audrey S. Black,Richard F. Bousley,Arnold D. Essenburg,Joseph A. Cornicelli,Ann Holmes,(unknown),Karen A. Kieft,Catherine Sekerke,(unknown)	28
12	Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted-pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-ones 1992 ·Journal of Medicinal Chemistry ·Drago R. Sliskovic,C. John Blankley,Brian R. Krause,Roger S. Newton,(unknown),W. Howard Roark,Bruce D. Roth,Catherine Sekerke,Maxwell K. Shaw,Richard L. Stanfield	16
13	Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus 1991 ·Journal of Medicinal Chemistry ·Bruce D. Roth,C. John Blankley,Alexander Chucholowski,Erika Ferguson,M. L. HOEFLE,Daniel F. Ortwine,Roger S. Newton,Catherine Sekerke,Drago R. Sliskovic,Michael Wilson	151
14	Inhibitors of cholesterol biosynthesis. 4. trans-6-[2-(Substituted-quinolinyl)ethenyl/ethyl]tetrahydro-4-hydroxy-2H-pyran-2-ones, a novel series of HMG-CoA reductase inhibitors 1991 ·Journal of Medicinal Chemistry ·Drago R. Sliskovic,(unknown),W. Howard Roark,Bruce D. Roth,Erika Ferguson,Brian R. Krause,Roger S. Newton,Catherine Sekerke,Maxwell K. Shaw	44
15	ChemInform Abstract: Inhibitors of Cholesterol Biosynthesis. Part 3. Tetrahydro‐4‐hydroxy‐6‐ (2‐(1H‐pyrrol‐1‐yl)ethyl)‐2H‐pyran‐2‐one Inhibitors of HMG‐CoA Reductase. Part 2. Effects of Introducing Substituents at Positions Three and Four of the Pyrrole Nucleus. 1991 ·ChemInform ·Bruce D. Roth,C. John Blankley,Alexander Chucholowski,Erika Ferguson,M. L. HOEFLE,Daniel F. Ortwine,Roger S. Newton,Catherine Sekerke,Drago R. Sliskovic,(unknown),(unknown)	1
16	Increased urinary excretion of glycosphingolipids in familial hypercholesterolemia. 1982 ·Journal of Lipid Research ·Snehajyoti Chatterjee,Catherine Sekerke,Peter O. Kwiterovich	24
17	Effects of Tunicamycin on the Cell‐Surface Binding, Internalization and Degradation of Low‐Density Lipoproteins in Human Fibroblasts 1981 ·European Journal of Biochemistry ·Subroto Chatterjee,Catherine Sekerke,Peter O. Kwiterovich	35
18	Effects of tunicamycin on the binding and degradation of low density lipoproteins and glycoprotein synthesis in cultured human fibroblasts. 1979 ·Journal of Biological Chemistry ·Sharmistha Chatterjee,Peter O. Kwiterovich,Catherine Sekerke	33
19	Alterations in cell surface glycosphingolipids and other lipid classes of fibroblasts in familial hypercholesterolemia. 1976 ·Proceedings of the National Academy of Sciences ·Sharmistha Chatterjee,Catherine Sekerke,Peter O. Kwiterovich	22

About Catherine Sekerke

Catherine Sekerke is a scholar working on Computational Theory and Mathematics, Surgery and Cancer Research, having authored 19 papers that have together received 645 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (11 papers), Computational Drug Discovery Methods (6 papers) and Plant biochemistry and biosynthesis (6 papers). The work is most often cited by research in Organic Chemistry (222 citations), Computational Theory and Mathematics (102 citations) and Biotechnology (48 citations). Catherine Sekerke has collaborated with scholars based in United States and China. Frequent co-authors include Peter O. Kwiterovich, Roger S. Newton, Bruce D. Roth, Drago R. Sliskovic, Erika Ferguson, Sharmistha Chatterjee, Bruce J. Auerbach, C. John Blankley, Michael Wilson and M. L. HOEFLE. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact